Form 4: Organogenesis Holdings Inc. Director Quintero Gilberto Reports Changes in Beneficial Ownership

Director Quintero Gilberto reports acquisition and disposal of Organogenesis Holdings Inc. Class A Common Stock and Restricted Stock Units.

Summary

• On February 19, 2025, Director Quintero Gilberto reported changes in beneficial ownership of Organogenesis Holdings Inc. securities.
• The report includes the acquisition of 49,575 shares of Class A Common Stock at $0 and the disposal of 190,245 shares.
• The director also received a grant of restricted stock units (RSUs) under the 2018 Equity Incentive Plan, which will vest in full on February 15, 2026.
• Each RSU represents the contingent right to receive one share of Organogenesis Class A common stock upon vesting.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing transactions. The RSU grant is a positive sign of aligning management with shareholder interests, but the disposal of shares could be interpreted negatively without further context.

Positives

• The grant of restricted stock units to a director aligns their interests with those of the shareholders, incentivizing long-term value creation.

Future Outlook

The vesting of the RSUs on February 15, 2026, suggests a long-term incentive for the director.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in the holdings of a director, which is relevant information for investors.

Stakeholder Impact

• Shareholders are informed about the transactions of a key insider, which can influence their investment decisions.
• The RSU grant can incentivize the director to work towards increasing shareholder value.

Key Dates

Keywords

Organogenesis Holdings Inc., ORGO, Form 4, Beneficial Ownership, Director, Quintero Gilberto, Restricted Stock Units, RSUs, Equity Incentive Plan, Class A Common Stock